Pfizer brings Indian generics maker to court over Xeljanz patent

Pfizer filed suit against an Indian pharmaceutical company on Friday over its application to market generic versions of Xeljanz XR.

Xeljanz XR is an extended …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Why Patient Engagement Must Be at the Center of Value-Based Care

Dave Bennett, Executive Vice President – Healthcare, pCare by Uniguest In the dynamic and ever-changing landscape of the healthcare industry, patient engagement continues to emerge

July 1, 2024

Ultra-processed foods linked to insomnia risk

Ultra-processed foods (UPF) may be associated with the insomnia experienced by an estimated one third of adults.

June 2, 2024

MHRA approves Marinus’ ganaxolone for CDKL5 deficiency

Share this article The approval of ganaxolone is based on results from a Phase III clinical trial in subjects aged two to 19 years. Credit:

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.